Vascular endothelial growth factor blockade elicits a stable metabolic shift in tumor cells: therapeutic implications

Research output: Contribution to journalArticle

Abstract

The metabolism of tumors differs remarkably from that of normal tissues, but whether this is a stable feature of tumor cells is largely unknown. Recent findings by independent teams indicate that antiangiogenic drugs cause a metabolic shift in tumor cells that is associated with increased malignancy. These results suggest therapy-driven evolutionary dynamics of tumor metabolism that could be therapeutically targeted.

Original languageEnglish
Pages (from-to)e1008307
JournalMolecular & cellular oncology
Volume3
Issue number2
DOIs
Publication statusPublished - Mar 2016

Keywords

  • Journal Article

Fingerprint Dive into the research topics of 'Vascular endothelial growth factor blockade elicits a stable metabolic shift in tumor cells: therapeutic implications'. Together they form a unique fingerprint.

  • Cite this